HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.

Abstract
The validity of laboratory tests that define bactericidal activity to predict antimicrobial efficacy was studied in rabbits with endocarditis due to Staphylococcus aureus, both nafcillin-nontolerant (NT) and nafcillin-tolerant (T). Infected rabbits were treated with nafcillin, clindamycin, chloramphenicol, or no drug (control) for up to 11 days; dosage was designed so that peak antibiotic serum concentration/minimal inhibitory concentration ratios were approximately 50. During treatment, peak and trough serum concentration/minimal bactericidal concentration ratios and peak and trough titers of serum bactericidal antibacterial activity were determined. The rank order of efficacy, as defined by survival, eradication of bacteremia, and sterilization of cardiac vegetations, was nafcillin = clindamycin greater than chloramphenicol greater than control, both adjusted and unadjusted for the challenge strain of S. aureus. Bactericidal activity (observed only with nafcillin plus S. aureus NT) was associated with lower bacterial counts in vegetations at four days but was otherwise unrelated to therapeutic outcome.
AuthorsR J Fass
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 149 Issue 6 Pg. 904-12 (Jun 1984) ISSN: 0022-1899 [Print] United States
PMID6736681 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Clindamycin
  • Nafcillin
  • Chloramphenicol
Topics
  • Analysis of Variance
  • Animals
  • Anti-Bacterial Agents (blood, pharmacology, therapeutic use)
  • Chloramphenicol (therapeutic use)
  • Clindamycin (therapeutic use)
  • Endocarditis, Bacterial (drug therapy, microbiology)
  • Microbial Sensitivity Tests
  • Nafcillin (therapeutic use)
  • Rabbits
  • Sepsis (drug therapy)
  • Staphylococcal Infections (drug therapy, microbiology)
  • Staphylococcus aureus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: